Thursday, 15 October 2026European Markets

ENVIPCO And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Loading stream...

(vianews) - envipco (envi.as), j.martins,sgps (jmt.ls), voss veksel ogland (vvl.ol) are the highest sales growth and return on equity stocks on this list.

here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. may these stocks be a good medium-term investment option?

1. envipco (envi.as)

202.8% sales growth and 4.02% return on equity

envipco holding n.v., together with its subsidiaries, designs, develops, manufactures, and sells or leases reverse vending machines (rvm) for the collection and processing of used beverage containers primarily in the netherlands, north america, and europe. the company provides technical support, rvm maintenance, and accounting services to the retail stores, bottlers, and distributors for containers redeemed through its machines. it also offers deposit, handling fees, scrap reconciliations, commodity brokerage, clearing house functions, and accounting services. in addition, the company provides materials handling services primarily in the northeastern part of the united states. envipco holding n.v. was incorporated in 1998 and is headquartered in amersfoort, the netherlands.

earnings per share

as for profitability, envipco has a trailing twelve months eps of €-0.09.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 4.02%.

more news about envipco.

2. j.martins,sgps (jmt.ls)

17.7% sales growth and 28.68% return on equity

jerónimo martins, sgps, s.a. operates in the food distribution and specialized retail sectors in portugal, poland, and colombia. the company operates through portugal retail; portugal cash & carry; poland retail; colombia retail; and others, eliminations and adjustments segments. it operates food stores under the biedronka name; and a chain of health and beauty stores under the hebe banner in poland, as well as food stores under the ara name in colombia. the company also operates supermarkets under the pingo doce banner; and cash and carry stores under the recheio name in portugal, and under the bodega del canasto name in colombia. in addition, it operates restaurants under the pingo doce name; para-pharmacies and petrol stations under bem-estar brand; and clothing under code brand. further, the company operates coffee shops and kiosks under the jeronymo name; and chocolates and confectionary retail stores under hussel name. additionally, the company engages in human resources top management, real estate management and administration, training, and saline brackish waters aquaculture; wholesale of fruit and vegetables; retail management, consultancy, and logistics activities; purchase and sale of real estate; growing of crops and farming of animals; retail sale of health and beauty products; manufacture of milk and dairy products; rental of air transport equipment; and provision of business portfolio management, financial, and sea passenger water transport services. it is also involved in the trading and distribution of consumer goods; retail and wholesale of non-food products; other business support service activities; and provision of services in the area of wholesale and retail distribution. the company was founded in 1792 and is headquartered in lisbon, portugal. jerónimo martins, sgps, s.a. operates as a subsidiary of sociedade francisco manuel dos santos, s.g.p.s., s.a.

earnings per share

as for profitability, j.martins,sgps has a trailing twelve months eps of €1.2.

pe ratio

j.martins,sgps has a trailing twelve months price to earnings ratio of 15.38. meaning, the purchaser of the share is investing €15.38 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 28.68%.

more news about j.martins,sgps.

3. voss veksel ogland (vvl.ol)

17.5% sales growth and 10.95% return on equity

voss veksel- og landmandsbank asa provides banking products and services to private individuals and companies in norway. the company offers saving accounts; car and other vehicle, home, small, and construction loans; overdrafts facilities; leasing services; bank guarantees; bank and payment cards; insurance products; and online and mobile banking services. the company was founded in 1843 and is based in voss, norway.

earnings per share

as for profitability, voss veksel ogland has a trailing twelve months eps of kr28.4.

pe ratio

voss veksel ogland has a trailing twelve months price to earnings ratio of 9.44. meaning, the purchaser of the share is investing kr9.44 for every norwegian krone of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 10.95%.

dividend yield

as claimed by morningstar, inc., the next dividend payment is on apr 26, 2024, the estimated forward annual dividend rate is 14.1 and the estimated forward annual dividend yield is 5.34%.

volume

today's last reported volume for voss veksel ogland is 592 which is 141.63% above its average volume of 245.

more news about voss veksel ogland.

4. pernod ricard (ri.pa)

7.9% sales growth and 12.18% return on equity

pernod ricard sa produces and sells wines and spirits worldwide. the company offers whiskey, vodka, gin, rum, liqueur and bitters, champagne, tequila and mezcal, and aperitif under the brands 100 pipers, aberlour, absolut, absolut elyx, altos, ararat, augier, avion, ballantine's, becherovka, beefeater, blenders pride, brancott estate, campo viejo, ceder's, chivas, church road, clan campbell, del maguey, george wyndham, green spot, havana club, imperial, imperial blue, italicus, j.p. wiser's, jacob's creek, jameson, jefferson's, kahlúa, kenwood, ki no bi, lillet, long john, l'orbe, lot no. 40, malfy, malibu, martell, method & madness, midleton very rare, minttu, monkey 47, mumm, olmeca, ostoya, passport scotch, pastis 51, pernod, perrier-jouët, plymouth gin, powers, rabbit hole, ramazzotti, redbreast, ricard, royal salute, royal stag, scapa, seagram's gin, secret speyside, smooth ambler, something special, st hugo, stoneleigh, suze, the glenlivet, tx, wyborowa, and ysios. it also provides non-alcoholic beverages under the brands ceder's, suze tonic 0%, cinzano spritz 0%, pacific, campo viejo sparkling 0%, and jacob's creek unvined. pernod ricard sa was founded in 1805 and is headquartered in paris, france.

earnings per share

as for profitability, pernod ricard has a trailing twelve months eps of €8.04.

pe ratio

pernod ricard has a trailing twelve months price to earnings ratio of 18.65. meaning, the purchaser of the share is investing €18.65 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.18%.

moving average

pernod ricard's value is under its 50-day moving average of €152.20 and way below its 200-day moving average of €169.76.

sales growth

pernod ricard's sales growth is 7.9% for the ongoing quarter and 7.9% for the next.

dividend yield

according to morningstar, inc., the next dividend payment is on nov 24, 2023, the estimated forward annual dividend rate is 4.7 and the estimated forward annual dividend yield is 3.17%.

yearly top and bottom value

pernod ricard's stock is valued at €149.95 at 07:20 est, way under its 52-week high of €218.00 and above its 52-week low of €140.50.

more news about pernod ricard.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,377 source documents archived
Query this data → isubstrate.com